Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Profiling of peripheral blood B-cell transcriptome in children who developed coeliac disease in a prospective study. | Heliyon | 2023 | 36718152 | PubTator, text mining | PubMed |
| CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy. | Clin Cancer Res | 2023 | 36716293 | PubTator, text mining | PubMed |
| CEACAM1 Is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma. | Dis Markers | 2023 | 36712923 | PubTator, text mining | PubMed |
| LncRNA SNHG5 Suppresses Cell Migration and Invasion of Human Lung Adenocarcinoma via Regulation of Epithelial-Mesenchymal Transition. | J Oncol | 2023 | 36711024 | PubTator, text mining | PubMed |
| Chronic stress in solid tumor development: from mechanisms to interventions. | J Biomed Sci | 2023 | 36707854 | PubTator, text mining | PubMed |
| Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy. | Cell Biosci | 2023 | 36694264 | PubTator, text mining | PubMed |
| Proline-Proline Dyad in the Fusion Peptide of the Murine β-Coronavirus Spike Protein's S2 Domain Modulates Its Neuroglial Tropism. | Viruses | 2023 | 36680255 | PubTator, text mining | PubMed |
| Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion. | Viruses | 2023 | 36680216 | PubTator, text mining | PubMed |
| TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma. | Cancers (Basel) | 2023 | 36672332 | PubTator, text mining | PubMed |
| Ras/MAPK signalling intensity defines subclonal fitness in a mouse model of hepatocellular carcinoma. | Elife | 2023 | 36656749 | PubTator, text mining | PubMed |
| Transcriptomic analyses of treatment-naïve pediatric ulcerative colitis patients and exploration of underlying disease pathogenesis. | J Transl Med | 2023 | 36647141 | PubTator, text mining | PubMed |
| Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma. | Sci Adv | 2023 | 36638181 | PubTator, text mining | PubMed |
| Identification and validation of circulating biomarkers for detection of liver cancer with antibody array. | Neoplasma | 2023 | 36620875 | PubTator, text mining | PubMed |
| Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion. | J Med Virol | 2023 | 36609964 | PubTator, text mining | PubMed |
| Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts. | Mol Oncol | 2023 | 36608258 | PubTator, text mining | PubMed |
| Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors. | Cancer Commun (Lond) | 2023 | 36585761 | PubTator, text mining | PubMed |
| In vitro and ex vivo modeling of enteric bacterial infections. | Gut Microbes | 2023 | 36576310 | PubTator, text mining | PubMed |
| Expression and Clinical Significance of Various Checkpoint Molecules in Advanced Osteosarcoma: Possibilities for Novel Immunotherapy. | Orthop Surg | 2023 | 36519392 | PubTator, text mining | PubMed |
| Protective and sex-specific effects of moderate dose folic acid supplementation on the placenta following assisted reproduction in mice. | FASEB J | 2023 | 36515682 | PubTator, text mining | PubMed |
| Susceptibility of SARS Coronavirus-2 infection in domestic and wild animals: a systematic review. | 3 Biotech | 2023 | 36514483 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=26